Phosphatidylinositol 3‐kinase inhibition potentiates glucocorticoid response in B‐cell acute lymphoblastic leukemia

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Cellular Physiology

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jcp.26135PMID 28777460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting the Breast Cancer Kinome

  2017cited by this paper
• Updates in the biology and therapy for infant acute lymphoblastic leukemia

  2017cited by this paper
• Clinical use of PI3K inhibitors in B-cell lymphoid malignancies: today and tomorrow

  2017cited by this paper
• Nuclear Localization of Diacylglycerol Kinase Alpha in K562 Cells Is Involved in Cell Cycle Progression

  2017influential reference
• MED28 Regulates Epithelial–Mesenchymal Transition Through NFκB in Human Breast Cancer Cells

  2017influential reference
• Dexamethasone Downregulates SLC7A5 Expression and Promotes Cell Cycle Arrest, Autophagy and Apoptosis in BeWo Cells

  2016cited by this paper
• BMP‐2 Induced Expression of PLCβ1 That is a Positive Regulator of Osteoblast Differentiation

  2016cited by this paper
• Critical Role of AMPK/FoxO3A Axis in Globular Adiponectin‐Induced Cell Cycle Arrest and Apoptosis in Cancer Cells

  2016cited by this paper
• The Non‐Conventional Effects of Glucocorticoids in Cancer

  2016cited by this paper
• Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B‐cell acute lymphoblastic leukaemia

  2016influential reference
• Different Effects of p52SHC1 and p52SHC3 on the Cell Cycle of Neurons and Neural Stem Cells

  2016cited by this paper
• Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and results in B-cell lymphocytosis in mice.

  2015influential reference
• Efficacy of phosphatidylinositol‐3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells

  2015cited by this paper
• PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors

  2015influential reference
• Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.

  2015cited by this paper
• The paradoxical role of IL-10 in immunity and cancer.

  2015cited by this paper
• The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL

  2015cited by this paper
• Phosphoinositide 3-kinase inhibitors in lymphoma

  2014cited by this paper
• Disturbed CXCR4/CXCL12 axis in paediatric precursor B‐cell acute lymphoblastic leukaemia

  2014cited by this paper
• Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies

  2014cited by this paper
• Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL

  2014cited by this paper
• PI3K and cancer: lessons, challenges and opportunities

  2014cited by this paper
• Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K/Akt pathway despite high PTEN protein levels

  2014cited by this paper
• IPI-145 antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia cells.

  2014cited by this paper
• EMP1, a novel poor prognostic factor in pediatric leukemia regulates prednisolone resistance, cell proliferation, migration and adhesion

  2014cited by this paper
• Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia

  2014cited by this paper
• The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1.

  2014cited by this paper
• Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia.

  2013influential reference
• Proliferation of PTEN‐deficient haematopoietic tumour cells is not affected by isoform‐selective inhibition of p110β PI3‐kinase and requires blockade of all class 1 PI3K activity

  2013cited by this paper
• Targeting nonclassical oncogenes for therapy in T-ALL.

  2012cited by this paper
• Synergistic activity of rapamycin and dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis.

  2012cited by this paper
• Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment

  2012influential reference
• mTOR signaling in growth control and disease.

  2012cited by this paper
• Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenografts

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B‐precursor acute lymphoblastic leukemia

  2012cited by this paper
• Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia

  2012cited by this paper
• The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia.

  2012cited by this paper
• Has MRD monitoring superseded other prognostic factors in adult ALL?

  2012cited by this paper
• Phosphorylated CXCR4 is associated with poor survival in adults with B‐acute lymphoblastic leukemia

  2011cited by this paper
• BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Biology of acute lymphoblastic leukemia (ALL): clinical and therapeutic relevance.

  2011cited by this paper
• Ligand-Independent Phosphorylation of the Glucocorticoid Receptor Integrates Cellular Stress Pathways with Nuclear Receptor Signaling

  2011cited by this paper
• MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo

  2010cited by this paper
• PI3K as a target for therapy in haematological malignancies.

  2010cited by this paper
• Phosphatidylinositol 3-kinase- inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals

  2010cited by this paper
• CXCL12 (SDF-1)/CXCR4 Pathway in Cancer

  2010cited by this paper
• The role of FKBP5 in cancer aetiology and chemoresistance

  2010cited by this paper
• Glucocorticoid use in acute lymphoblastic leukaemia.

  2010cited by this paper
• A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia

  2009cited by this paper
• CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

  2009cited by this paper
• Translational control by RGS2

  2009cited by this paper
• PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability.

  2008cited by this paper
• Aquaporins and cell migration

  2008cited by this paper
• Connective tissue growth factor (CTGF) and cancer progression.

  2008cited by this paper
• Relapsed acute lymphoblastic leukemia: Current status and future opportunities

  2008cited by this paper
• Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance.

  2006influential reference
• Treatment of acute lymphoblastic leukemia.

  2006cited by this paper
• The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia.

  2006cited by this paper
• The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

  2006cited by this paper
• Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

  2005cited by this paper
• Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1

  2005cited by this paper
• Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis

  2005cited by this paper
• Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor.

  2005cited by this paper
• Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.

  2004cited by this paper
• Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.

  2003cited by this paper
• Glucocorticoid resistance - what is known?

  2002cited by this paper
• Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers

  2000cited by this paper
• Steroid hormone receptors: Evolution, ligands, and molecular basis of biologic function

  1999cited by this paper
• Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.

  1998cited by this paper
• p110δ, a Novel Phosphatidylinositol 3-Kinase Catalytic Subunit That Associates with p85 and Is Expressed Predominantly in Leukocytes*

  1997influential reference
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

  1984cited by this paper
• [Treatment of acute lymphoblastic leukemia].

  1971cited by this paper

• The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir

  2026cites this paper
• Dexmedetomidine Suppresses Mitochondrial Autophagy and Apoptosis While Promoting Proliferation in Breast Cancer Cells in vitro via PI3K/AKT Signaling

  2025cites this paper
• Cinobufagin Suppresses T-ALL via USP7-Mediated Inhibition of NOTCH1/PI3K Signaling Pathways.

  2025cites this paper
• A New Indole Derivative, LWX-473, Overcomes Glucocorticoid Resistance in Jurkat Cells by Activating Mediators of Apoptosis.

  2024cites this paper
• NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLL-r B-ALL by regulating NR3C1 expression.

  2024cites this paper
• New clinical treatment plan for acute lymphoblastic leukemia after whole genome sequencing: An update of the development of new technologies for genome editing

  2024cites this paper
• The PI3K signaling pathway; from normal lymphopoiesis to lymphoid malignancies

  2024cites this paper
• In vivo activity of the dual PI3Kδ and PI3Kγ inhibitor duvelisib against pediatric acute lymphoblastic leukemia xenografts

  2023cites this paper
• PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities

  2023cites this paper
• GingerenoneA overcomes dexamethasone resistance by activating apoptosis and inhibiting cell proliferation in pediatric T‐ALL cells

  2023cites this paper
• PI3Kδ Inhibition Potentiates Glucocorticoids in B-lymphoblastic Leukemia by Decreasing Receptor Phosphorylation and Enhancing Gene Regulation

  2023cites this paper
• Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia—The State-of-the-Art Knowledge and Future Prospects

  2022cites this paper
• PI3K Targeting in Non-solid Cancer.

  2022cites this paper
• Bone Marrow Aging and the Leukaemia-Induced Senescence of Mesenchymal Stem/Stromal Cells: Exploring Similarities

  2022cites this paper
• Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children

  2022cites this paper
• The Dynamicity of Acute Ozone-Induced Systemic Leukocyte Trafficking and Adrenal-Derived Stress Hormones.

  2021cites this paper
• Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene?

  2021cites this paper
• Pan-PI3Ki targets multiple B-ALL microenvironment interactions that fuel systemic and CNS relapse

  2021cites this paper
• Sensitization to Drug Treatment in Precursor B-Cell Acute Lymphoblastic Leukemia Is Not Achieved by Stromal NF-κB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity

  2021cites this paper
• Oxaliplatin Induces Cell Cycle Arrest and Apoptosis in T-leukemia Cells through Mitochondrial and PI3K/Akt Signaling Pathways

  2021cites this paper
• PON2 blockade overcomes dexamethasone resistance in acute lymphoblastic leukemia

  2021cites this paper
• B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients?

  2020cites this paper
• Targeting Wnt/β‐catenin and PI3K/Akt/mTOR pathways in T‐cell acute lymphoblastic leukemia

  2020cites this paper
• Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies.

  2020cites this paper
• The potentials of immune checkpoints for the treatment of blood malignancies.

  2020cites this paper
• Pathogenesis of pediatric B-cell acute lymphoblastic leukemia: Molecular pathways and disease treatments

  2020cites this paper
• Targeting PI3K Signaling in Acute Lymphoblastic Leukemia

  2019influential citation
• Interrogating the Mechanistic Basis for Cytokine-Mediated Glucocorticoid Resistance in Lymphoid-Driven Diseases

  2019cites this paper
• Resistance to Targeted Therapies in Lymphomas

  2019cites this paper
• Molecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies

  2019cites this paper
• New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: Recent advances

  2019cites this paper
• Targeting steroid resistance in T-cell acute lymphoblastic leukemia.

  2019cites this paper
• Targeting mTOR in Acute Lymphoblastic Leukemia

  2019cites this paper
• Mechanisms of Glucocorticoid Response and Resistance in Lymphoid Malignancies

  2019cites this paper
• Roles and clinical implications of microRNAs in acute lymphoblastic leukemia

  2018cites this paper
• The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia

  2018cites this paper
• Targeting the phosphatidylinositol 3‐kinase/Akt/mechanistic target of rapamycin signaling pathway in B‐lineage acute lymphoblastic leukemia: An update

  2018cites this paper
• The many faces of IKZF 1 in B-cell precursor acute lymphoblastic leukemia

  2018cites this paper
• Effect of Notch and PARP Pathways’ Inhibition in Leukemic Cells

  2018cites this paper